PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy (PERYTON)
PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy of Biochemical Failure After Radical Prostatectomy for Prostate Cancer
Sponsor: Dutch Cancer Society
A PHASE3 clinical study on Cancer Recurrence and Prostate Cancer, this trial is actively recruiting participants. The trial is conducted by Dutch Cancer Society and has accumulated 8 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Mar 2024 — Jul 2024 [monthly]
Recruiting PHASE3
-
May 2022 — Mar 2024 [monthly]
Recruiting PHASE3
▶ Show 3 earlier versions
-
Sep 2021 — May 2022 [monthly]
Recruiting PHASE3
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE3
First recorded
Sep 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dutch Cancer Society
- University Medical Center Groningen
For direct contact, visit the study record on ClinicalTrials.gov .